{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:37:01Z","timestamp":1771375021187,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["J59H06000160001"],"award-info":[{"award-number":["J59H06000160001"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["F52F16001420001"],"award-info":[{"award-number":["F52F16001420001"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Ment Health Syst"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Italy can be viewed as a laboratory to assess the quality of mental healthcare delivered in a community-oriented system, especially for severe mental disorders, such as personality disorders. Although initiatives based on clinical indicators for assessing the quality of mental healthcare have been developed by transnational-organisations, there is still no widespread practice of measuring the quality of care pathways delivered to patients with severe mental disorders in a community-oriented system, especially using administrative healthcare databases. The aim of the study is to evaluate the quality of care delivered to patients with personality disorders taken-in-care by mental health services of four Italian regions (Lombardy, Emilia-Romagna, Lazio, Sicily).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A set of thirty-three clinical indicators, concerning accessibility, appropriateness, continuity, and safety of care, was implemented using regional healthcare utilization databases, containing data on mental health treatments and diagnosis, hospital admissions, outpatient interventions and exams and drug prescriptions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>RESULTS<\/jats:title>\n                <jats:p>31,688 prevalent patients with personality disorders treated in 2015 were identified, of whom 2,331 newly taken-in-care. One-in-10 patients received a standardized assessment, the treatment discontinuity affected half of the cases. 12.7% of prevalent patients received at least one hospitalization, 10.6% in the newly taken-in-care cohort. 6-out-of-10 patients had contact with community-services within 14 days from hospital discharge. Access to psychotherapy and psychoeducational treatments was low and delivered with a low intensity. The median of psychosocial interventions per person-year was 19.1 and 9.4, respectively, in prevalent and newly taken-in-care cases. Nearly 50% of patients received pharmacological treatments.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Healthcare utilization databases were used to systematically evaluate and assess service delivery across regional mental health systems; suggesting that in Italy the public mental health services provide to individuals with personality disorders suboptimal treatment paths.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13033-023-00603-9","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T07:02:37Z","timestamp":1697180557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Assessing the quality of the care offer for people with personality disorders in Italy: the QUADIM project. A multicentre research based on the database of use of Mental Health services"],"prefix":"10.1186","volume":"17","author":[{"given":"Michele","family":"Sanza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2105-4572","authenticated-orcid":false,"given":"Matteo","family":"Monzio Compagnoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6631-5393","authenticated-orcid":false,"given":"Giulia","family":"Caggiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliana","family":"Allevi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7142-700X","authenticated-orcid":false,"given":"Angelo","family":"Barbato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannette","family":"Campa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2422-6528","authenticated-orcid":false,"given":"Flavia","family":"Carle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0361-7263","authenticated-orcid":false,"given":"Barbara","family":"D\u2019avanzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1124-0600","authenticated-orcid":false,"given":"Teresa","family":"Di Fiandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6955-8983","authenticated-orcid":false,"given":"Lucia","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Gaddini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio","family":"Saponaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7620-3080","authenticated-orcid":false,"given":"Salvatore","family":"Scondotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0660-7853","authenticated-orcid":false,"given":"Valeria D","family":"Tozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Lorusso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Giordani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1034-8444","authenticated-orcid":false,"given":"Giovanni","family":"Corrao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6806-5199","authenticated-orcid":false,"given":"Antonio","family":"Lora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,13]]},"reference":[{"key":"603_CR1","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1176\/appi.ajp.2009.08121825","volume":"166","author":"JG Gunderson","year":"2009","unstructured":"Gunderson JG. Borderline personality disorder: ontogeny of a diagnosis. Am J Psychiatry. 2009;166:530\u20139.","journal-title":"Am J Psychiatry"},{"key":"603_CR2","first-page":"111","volume-title":"Contemporary directions in psychopathology: scientific foundations of the DSM-V and ICD-11","author":"M Theodore","year":"2010","unstructured":"Theodore M. A sociocultural conception of the borderline personality disorder epidemic. Contemporary directions in psychopathology: scientific foundations of the DSM-V and ICD-11. New York, NY, US: The Guilford Press; 2010. 111\u201323."},{"key":"603_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eurpsy.2018.10.010","volume":"56","author":"I \u00c1lvarez-Tom\u00e1s","year":"2019","unstructured":"\u00c1lvarez-Tom\u00e1s I, Ruiz J, Guilera G, Bados A. Long-term clinical and functional course of borderline personality disorder: a meta-analysis of prospective studies. Eur Psychiatry. 2019;56:75\u201383.","journal-title":"Eur Psychiatry"},{"key":"603_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11920-011-0249-4","volume":"14","author":"M Goodman","year":"2012","unstructured":"Goodman M, Roiff T, Oakes AH, Paris J. Suicidal risk and management in borderline personality disorder. Curr Psychiatry Rep. 2012;14:79\u201385.","journal-title":"Curr Psychiatry Rep"},{"key":"603_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/08039480500320025","volume":"59","author":"M Pompili","year":"2005","unstructured":"Pompili M, Girardi P, Ruberto A, Tatarelli R. Suicide in borderline personality disorder: a meta-analysis. Nord J Psychiatry. 2005;59:319\u201324.","journal-title":"Nord J Psychiatry"},{"key":"603_CR6","doi-asserted-by":"crossref","unstructured":"Olesen J, Gustavsson A, Svensson M, Wittchen H-U, J\u00f6nsson B et al. CDBE2010 study group,. The economic cost of brain disorders in Europe. Eur J Neurol. 2012;19:155\u201362.","DOI":"10.1111\/j.1468-1331.2011.03590.x"},{"key":"603_CR7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1192\/bjp.bp.109.070482","volume":"196","author":"DI Soeteman","year":"2010","unstructured":"Soeteman DI, Verheul R, Delimon J, Meerman AMMA, van den Eijnden E, Rossum BV, et al. Cost-effectiveness of psychotherapy for cluster B personality disorders. Br J Psychiatry. 2010;196:396\u2013403.","journal-title":"Br J Psychiatry"},{"key":"603_CR8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1001\/jamapsychiatry.2016.4287","volume":"74","author":"IA Cristea","year":"2017","unstructured":"Cristea IA, Gentili C, Cotet CD, Palomba D, Barbui C, Cuijpers P. Efficacy of Psychotherapies for Borderline personality disorder: a systematic review and Meta-analysis. JAMA Psychiatry. 2017;74:319\u201328.","journal-title":"JAMA Psychiatry"},{"key":"603_CR9","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1176\/appi.ajp.2009.09010039","volume":"166","author":"SF McMain","year":"2009","unstructured":"McMain SF, Links PS, Gnam WH, Guimond T, Cardish RJ, Korman L, et al. A randomized trial of dialectical behavior therapy versus general psychiatric management for borderline personality disorder. Am J Psychiatry. 2009;166:1365\u201374.","journal-title":"Am J Psychiatry"},{"key":"603_CR10","unstructured":"Linehan M. DBT Skills training manual. Guilford Publications; 2014."},{"key":"603_CR11","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1097\/HRP.0000000000000113","volume":"24","author":"LW Choi-Kain","year":"2016","unstructured":"Choi-Kain LW, Albert EB, Gunderson JG. Evidence-based treatments for Borderline personality disorder: implementation, integration, and stepped Care. Harv Rev Psychiatry. 2016;24:342\u201356.","journal-title":"Harv Rev Psychiatry"},{"key":"603_CR12","unstructured":"National Collaborating Centre for Mental Health (UK). Borderline Personality Disorder: Treatment and Management [Internet]. Leicester (UK): British Psychological Society; 2009 [cited 2021 Feb 25]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK55403\/."},{"key":"603_CR13","unstructured":"National Health and Medical Research Council. Clinical Practice Guideline for the Management of Borderline Personality Disorder [Internet]. 2012 [cited 2021 Feb 25]. Available from: https:\/\/www.nhmrc.gov.au\/about-us\/publications\/clinical-practice-guideline-borderline-personality-disorder#block-views-block-file-attachments-content-block-1."},{"key":"603_CR14","unstructured":"General Directorate of Health and Social Policies, Emilia-Romagna Region. Mental Health Service, Pathological Addictions and Health in Prisons of the Emilia-Romagna Region. Guidelines for the treatment of severe personality disorders. 2013."},{"key":"603_CR15","unstructured":"Italian Ministry of Health. 6th Italian Annual report on Mental Health, year 2020 [Internet]. 2022 [cited 2022 Nov 8]. Available from: https:\/\/www.salute.gov.it\/imgs\/C_17_pubblicazioni_3212_allegato.pdf."},{"key":"603_CR16","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1176\/ps.62.11.pss6211_1381","volume":"62","author":"MLM Hermens","year":"2011","unstructured":"Hermens MLM, van Splunteren PT, van den Bosch A, Verheul R. Barriers to implementing the clinical guideline on borderline personality disorder in the Netherlands. Psychiatr Serv. 2011;62:1381\u20133.","journal-title":"Psychiatr Serv"},{"key":"603_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/13651501.2016.1235202","volume":"21","author":"E Paolini","year":"2017","unstructured":"Paolini E, Mezzetti FAF, Pierri F, Moretti P. Pharmacological treatment of borderline personality disorder: a retrospective observational study at inpatient unit in Italy. Int J Psychiatry Clin Pract. 2017;21:75\u20139.","journal-title":"Int J Psychiatry Clin Pract"},{"key":"603_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13033-018-0223-1","volume":"12","author":"C Barbui","year":"2018","unstructured":"Barbui C, Papola D, Saraceno B. Forty years without mental hospitals in Italy. Int J Ment Health Syst. 2018;12:43.","journal-title":"Int J Ment Health Syst"},{"key":"603_CR19","unstructured":"Gazzetta Ufficiale. Decreto Legislativo 10 agosto 2018, n. 101. [Internet]. [cited 2023 May 9]. Available from: https:\/\/www.gazzettaufficiale.it\/eli\/id\/2018\/09\/04\/18G00129\/sg."},{"key":"603_CR20","unstructured":"EUR-Lex. Regulation (EU) 2016\/679 of the European parliament and of the council of 27 April 2016. [Internet]. Available from: https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:32016R0679&from=EN."},{"key":"603_CR21","doi-asserted-by":"publisher","first-page":"e007140","DOI":"10.1136\/bmjopen-2014-007140","volume":"5","author":"G Corrao","year":"2015","unstructured":"Corrao G, Soranna D, Merlino L, Monzani E, Vigan\u00f2 C, Lora A. Do patterns of mental healthcare predict treatment failure in young people with schizophrenia? Evidence from an italian population-based cohort study. BMJ Open. 2015;5:e007140.","journal-title":"BMJ Open"},{"key":"603_CR22","unstructured":"Corrao G, Barbato A, D\u2019Avanzo B, Di Fiandra T, Ferrara L, Gaddini A et al. Does the mental health system provide effective coverage to people with schizophrenic disorder? A self-controlled case series study in Italy. Soc Psychiatry Psychiatr Epidemiol. 2021."},{"key":"603_CR23","first-page":"728","volume":"28","author":"A Lora","year":"2016","unstructured":"Lora A, Monzani E, Ibrahim B, Soranna D, Corrao G. Routine quality care assessment of schizophrenic disorders using information systems. Int J Qual Health Care. 2016;28:728\u201333.","journal-title":"Int J Qual Health Care"},{"key":"603_CR24","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1017\/S2045796022000014","volume":"31","author":"A Lora","year":"2022","unstructured":"Lora A, Monzio Compagnoni M, Allevi L, Barbato A, Carle F, D\u2019avanzo B, et al. The quality of mental health care delivered to patients with schizophrenia and related disorders in the italian mental health system. The QUADIM project: a multi-regional italian investigation based on healthcare utilisation databases. Epidemiol Psychiatr Sci. 2022;31:e15.","journal-title":"Epidemiol Psychiatr Sci"},{"key":"603_CR25","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1093\/intqhc\/mzy186","volume":"31","author":"G Corrao","year":"2019","unstructured":"Corrao G, Rea F, Di Martino M, Lallo A, Davoli M, DlE PlALMA R, et al. Effectiveness of adherence to recommended clinical examinations of diabetic patients in preventing diabetes-related hospitalizations. Int J Qual Health Care. 2019;31:464\u201372.","journal-title":"Int J Qual Health Care"},{"key":"603_CR26","unstructured":"Conferenza Unificata Stato-Regioni. Definizione dei percorsi di cura da attivare nei Dipartimenti di Salute Mentale per i disturbi schizofrenici, i disturbi dell\u2019umore e i disturbi gravi di personalit\u00e0 [Internet]. 2014 [cited 2021 Jan 20]. Available from: http:\/\/www.salute.gov.it\/portale\/documentazione\/p6_2_2_1.jsp?lingua=italiano&id=2461"},{"key":"603_CR27","unstructured":"National Collaborating Centre for Mental Health (UK). Psychosis and Schizophrenia in Adults: Treatment and Management: Updated Edition 2014 [Internet]. London: National Institute for Health and Care Excellence (UK).; 2014 [cited 2021 Nov 23]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK248060\/."},{"key":"603_CR28","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.3390\/jcm12093297","volume":"12","author":"M Monzio Compagnoni","year":"2023","unstructured":"Monzio Compagnoni M, Caggiu G, Allevi L, Barbato A, Carle F, D\u2019Avanzo B, et al. Assessment and Monitoring of the quality of clinical pathways in patients with depressive Disorders: results from a Multiregional Italian Investigation on Mental Health Care Quality (the QUADIM Project). J Clin Med. 2023;12:3297.","journal-title":"J Clin Med"},{"key":"603_CR29","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/s12888-023-04921-7","volume":"23","author":"B D\u2019Avanzo","year":"2023","unstructured":"D\u2019Avanzo B, Barbato A, Monzio Compagnoni M, Caggiu G, Allevi L, Carle F, et al. The quality of mental health care for people with bipolar disorders in the italian mental health system: the QUADIM project. BMC Psychiatry. 2023;23:424.","journal-title":"BMC Psychiatry"},{"key":"603_CR30","unstructured":"Higgins JPT, The Cochrane Collaboration Group. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] [Internet]. 2011 [cited 2022 Aug 9]. Available from: www.cochrane-handbook.org."},{"key":"603_CR31","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360.","journal-title":"BMJ"},{"key":"603_CR32","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.comppsych.2008.01.007","volume":"49","author":"MI Korzekwa","year":"2008","unstructured":"Korzekwa MI, Dell PF, Links PS, Thabane L, Webb SP. Estimating the prevalence of borderline personality disorder in psychiatric outpatients using a two-phase procedure. Compr Psychiatr. 2008;49:380\u20136.","journal-title":"Compr Psychiatr"},{"key":"603_CR33","unstructured":"Verheul R, van den Brink W, Spinhoven S et al. Practice guidelines for clinical assessments of DSM IV personality disorders. Tijdschrift voor Psychiatrie. 2000;409\u201322."},{"key":"603_CR34","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.psc.2018.07.008","volume":"41","author":"WD Ellison","year":"2018","unstructured":"Ellison WD, Rosenstein LK, Morgan TA, Zimmerman M. Community and clinical epidemiology of Borderline personality disorder. Psychiatr Clin North Am. 2018;41:561\u201373.","journal-title":"Psychiatr Clin North Am"},{"key":"603_CR35","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1017\/S0033291708004911","volume":"39","author":"J Coid","year":"2009","unstructured":"Coid J, Yang M, Bebbington P, Moran P, Brugha T, Jenkins R, et al. Borderline personality disorder: health service use and social functioning among a national household population. Psychol Med. 2009;39:1721\u201331.","journal-title":"Psychol Med"},{"key":"603_CR36","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1176\/appi.ajp.161.11.2108","volume":"161","author":"MC Zanarini","year":"2004","unstructured":"Zanarini MC, Frankenburg FR, Hennen J, Reich DB, Silk KR. Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission. Am J Psychiatry. 2004;161:2108\u201314.","journal-title":"Am J Psychiatry"},{"key":"603_CR37","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1080\/13651501.2019.1576904","volume":"23","author":"F Riffer","year":"2019","unstructured":"Riffer F, Farkas M, Streibl L, Kaiser E, Sprung M. Psychopharmacological treatment of patients with borderline personality disorder: comparing data from routine clinical care with recommended guidelines. Int J Psychiatry Clin Pract. 2019;23:178\u201388.","journal-title":"Int J Psychiatry Clin Pract"},{"key":"603_CR38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4088\/JCP.08r04526gre","volume":"71","author":"T Ingenhoven","year":"2010","unstructured":"Ingenhoven T, Lafay P, Rinne T, Passchier J, Duivenvoorden H. Effectiveness of pharmacotherapy for severe personality disorders: meta-analyses of randomized controlled trials. J Clin Psychiatry. 2010;71:14\u201325.","journal-title":"J Clin Psychiatry"},{"key":"603_CR39","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s40263-021-00855-4","volume":"35","author":"G Gartlehner","year":"2021","unstructured":"Gartlehner G, Crotty K, Kennedy S, Edlund MJ, Ali R, Siddiqui M, et al. Pharmacological treatments for Borderline personality disorder: a systematic review and Meta-analysis. CNS Drugs. 2021;35:1053\u201367.","journal-title":"CNS Drugs"},{"key":"603_CR40","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1192\/bjp.bp.108.062984","volume":"196","author":"K Lieb","year":"2010","unstructured":"Lieb K, V\u00f6llm B, R\u00fccker G, Timmer A, Stoffers JM. Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials. Br J Psychiatry. 2010;196:4\u201312.","journal-title":"Br J Psychiatry"},{"key":"603_CR41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11920-020-01164-1","volume":"22","author":"J Stoffers-Winterling","year":"2020","unstructured":"Stoffers-Winterling J, Storeb\u00f8 OJ, Lieb K. Pharmacotherapy for Borderline personality disorder: an update of published, unpublished and ongoing studies. Curr Psychiatry Rep. 2020;22:37.","journal-title":"Curr Psychiatry Rep"},{"key":"603_CR42","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1516\/1VYH-YL0W-WRDT-YT7F","volume":"84","author":"M Chiesa","year":"2003","unstructured":"Chiesa M, Fonagy P, Holmes J. When less is more: an exploration of psychoanalytically oriented hospital-based treatment for severe personality disorder. Int J Psychoanal. 2003;84:637\u201350.","journal-title":"Int J Psychoanal"},{"key":"603_CR43","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1745-6215-11-18","volume":"11","author":"P Moran","year":"2010","unstructured":"Moran P, Borschmann R, Flach C, Barrett B, Byford S, Hogg J, et al. The effectiveness of joint crisis plans for people with borderline personality disorder: protocol for an exploratory randomised controlled trial. Trials. 2010;11:18.","journal-title":"Trials"},{"key":"603_CR44","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1521\/pedi.18.3.240.35443","volume":"18","author":"J Paris","year":"2004","unstructured":"Paris J. Is hospitalization useful for suicidal patients with borderline personality disorder? J Pers Disord. 2004;18:240\u20137.","journal-title":"J Pers Disord"},{"key":"603_CR45","first-page":"2946","volume":"126","author":"L Mehlum","year":"2006","unstructured":"Mehlum L, Jensen AI. [Suicidal behaviour in borderline personality disorder]. Tidsskr nor Laegeforen. 2006;126:2946\u20139.","journal-title":"Tidsskr nor Laegeforen"},{"key":"603_CR46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.encep.2014.10.008","volume":"41","author":"L Cailhol","year":"2015","unstructured":"Cailhol L, Thalamas C, Garrido C, Birmes P, Lapeyre-Mestre M. [Mental health service utilization among borderline personality disorder patients inpatient]. Encephale. 2015;41:115\u201322.","journal-title":"Encephale"},{"key":"603_CR47","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1521\/pedi.2010.24.4.412","volume":"24","author":"TJ Trull","year":"2010","unstructured":"Trull TJ, Jahng S, Tomko RL, Wood PK, Sher KJ. Revised NESARC personality disorder diagnoses: gender, prevalence, and comorbidity with substance dependence disorders. J Pers Disord. 2010;24:412\u201326.","journal-title":"J Pers Disord"},{"key":"603_CR48","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1521\/pedi_2012_26_093","volume":"28","author":"RL Tomko","year":"2014","unstructured":"Tomko RL, Trull TJ, Wood PK, Sher KJ. Characteristics of borderline personality disorder in a community sample: comorbidity, treatment utilization, and general functioning. J Pers Disord. 2014;28:734\u201350.","journal-title":"J Pers Disord"},{"key":"603_CR49","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1001\/archpsyc.58.6.590","volume":"58","author":"S Torgersen","year":"2001","unstructured":"Torgersen S, Kringlen E, Cramer V. The prevalence of personality disorders in a community sample. Arch Gen Psychiatry. 2001;58:590\u20136.","journal-title":"Arch Gen Psychiatry"},{"key":"603_CR50","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40479-020-00133-7","volume":"7","author":"J Hutsebaut","year":"2020","unstructured":"Hutsebaut J, Willemsen E, Bachrach N, Van R. Improving access to and effectiveness of mental health care for personality disorders: the guideline-informed treatment for personality disorders (GIT-PD) initiative in the Netherlands. Borderline Personal Disord Emot Dysregul. 2020;7:16.","journal-title":"Borderline Personal Disord Emot Dysregul"}],"container-title":["International Journal of Mental Health Systems"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13033-023-00603-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13033-023-00603-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13033-023-00603-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T01:22:37Z","timestamp":1700356957000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmhs.biomedcentral.com\/articles\/10.1186\/s13033-023-00603-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,13]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["603"],"URL":"https:\/\/doi.org\/10.1186\/s13033-023-00603-9","relation":{},"ISSN":["1752-4458"],"issn-type":[{"value":"1752-4458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,13]]},"assertion":[{"value":"3 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GC received research support from the European Community (EC), the Italian Agency of Drug (AIFA), and the Italian Ministry for University and Research (MIUR). He took part to a variety of projects that were funded by pharmaceutical companies (i.e., Novartis, GSK, Roche, AMGEN and BMS). He also received honoraria as member of Advisory Board from Roche. Author AL was employed by ASST Lecco. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were carried out in accordance with the Declaration of Helsinki. The Ethical Committee of the University of Milano-Bicocca approved the study protocol (Protocol number 497, Year 2019) and established that the study (i) was exempt from patients informed consent (according to General Authorization for the Processing of Personal Data for Scientific Research Purposes Issued by the Italian Privacy Authority on August 10, 2018; ); (ii) provides sufficient guarantees of individual records anonymity; and (iii) was designed according to quality standards of good practice of observational research based on secondary data. Informed consent was waived by the Ethical Committee of the University of Milano-Bicocca.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"31"}}